SMNROTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SMNRW
Semnur Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.43+0.03 (+6.75%)
Close on Oct 19, 2026
- Market cap
- $98.30M
- P/E (TTM)
- –
- Dividend yield
- –
Semnur Pharmaceuticals statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Income (trailing twelve months)
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$167.55M | -$21.40M |
| Net Income | -$167.68M | -$22.46M |
| EBITDA | -$167.55M | -$16.91M |
| EPS (Diluted) | -$0.83 | -$0.83 |
Returns
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Return on Assets (ROA) | -13384.8% | -40.9% |
Balance sheet
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $39.00K | $61.43M |
| Net Cash (Debt) | $39.00K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$29.67M | $49.09M |
| Book Value Per Share | -$0.13 | $1.37 |
| Tangible Book Value | -$29.67M | $23.52M |
| Working Capital | -$9.48M | $76.81M |
Financial position
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 0.11 | 3.34 |
| Quick Ratio | 0.00 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$10.54M | -$12.35M |
Efficiency
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$16.77M | -$703.34K |
| Employee Count | 10 | 74 |
Shares
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 230,209,000 | 58,127,000 |
| Shares Change (YoY) | 9.94% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Shares Held by Institutions | 0.00% | 59.4% |
Scores
| Measure | Semnur Pharmaceuticals | Industry median |
|---|---|---|
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Semnur Pharmaceuticals's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.